Playback speed
10 seconds
Ongoing Clinical Trials in Advanced Thyroid Cancer: RET Inhibitors (LOXO-292 & BLU-667), NTRK Inhibitors (Larotrectinib, Entrectinib) & IO
119 views
March 18, 2020
Login to view comments.
Click here to Login